Literature DB >> 11006041

Cervical cancer outcomes analysis: impact of age, race, and comorbid illness on hospitalizations for invasive carcinoma of the cervix.

S E Brooks1, T T Chen, A Ghosh, C D Mullins, J F Gardner, C R Baquet.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the association of age, race, and comorbid illness with procedures and complications in hospitalized patients with invasive carcinoma of the cervix in a statewide population-based database over a 3-year period.
METHODS: Hospitalizations were classified into homogeneous subgroups based on a diagnosis of invasive cervical cancer. Cancer-related complications and comorbid diseases were evaluated. chi(2) and t tests determined differences in means or proportions. Linear regression techniques were applied to build models for hospitalization charges and lengths of stay (LOS).
RESULTS: There were 1009 admissions. The mean age was 49.5, with a median age of 46 (21-100, SD 15.4). Of the total, 606/1009 (60%) were white, 354/1009 (35%) were African-American (AA), and 5% were "other" races. AAs were more likely to have Medicaid or be uninsured (44% vs 23%, P = 0. 001) and were more likely to be admitted for an emergency (unadjusted odds ratio (OR) = 1.6; 1.2-2.2), to have a comorbid illness (P = 0.001), to be admitted for a cancer-related complication (P = 0.036), to be admitted for a transfusion (P = 0. 01), and to be admitted for radiation therapy rather than surgery (P = 0.001). The following were associated with LOS and higher hospital costs: emergency admissions for complications of cancer, comorbid illness, and older age.
CONCLUSIONS: Racial differences exist in patterns of admission, type of therapy, and severity of illness; however, there were no differences in charges or LOS for similar procedures. The large percentage of African-Americans uninsured or insured by government-supported programs indicates the potential impact of public policy on the care of these patients. Socioeconomic status rather than phenotypic appearance may be a more important determinant of outcome. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 11006041     DOI: 10.1006/gyno.2000.5901

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  13 in total

1.  The contextual model of HRQoL: a paradigm for expanding the HRQoL framework.

Authors:  Kimlin Tam Ashing-Giwa
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

2.  Factors associated with place of death of cancer patients in the Mexico City Metropolitan area.

Authors:  Marylou Cárdenas-Turanzas; María Teresa Carrillo; Horacio Tovalín-Ahumada; Linda Elting
Journal:  Support Care Cancer       Date:  2006-10-05       Impact factor: 3.603

3.  Clinical, sociodemographic, and local system factors associated with a hospital death among cancer patients.

Authors:  Marylou Cárdenas-Turanzas; Richard M Grimes; Eduardo Bruera; Beth Quill; Guillermo Tortolero-Luna
Journal:  Support Care Cancer       Date:  2005-04-21       Impact factor: 3.603

4.  The Human and Economic Burden of Cervical Cancer in Texas.

Authors:  Jan M Eberth; Pratibha Prarelkar; Hoang Nguyen; Charlotte Sun; Jennifer Irvin-Vidrine; Linda S Elting
Journal:  Tex Public Health J       Date:  2013-01

5.  Avoidable tragedies: Disparities in healthcare access among medically underserved women diagnosed with cervical cancer.

Authors:  Lois M Ramondetta; Larissa A Meyer; Kathleen M Schmeler; Maria E Daheri; Jessica Gallegos; Michael Scheurer; Jane R Montealegre; Andrea Milbourne; Matthew L Anderson; Charlotte C Sun
Journal:  Gynecol Oncol       Date:  2015-10-21       Impact factor: 5.482

6.  Racial disparities in cervical cancer mortality in an African American and European American cohort in South Carolina.

Authors:  Swann Arp Adams; Alexandria Fleming; Heather M Brandt; Deborah Hurley; Susan Bolick-Aldrich; Sharon M Bond; James R Hebert
Journal:  J S C Med Assoc       Date:  2009-12

7.  ARHGAP1 overexpression inhibits proliferation, migration and invasion of C-33A and SiHa cell lines.

Authors:  Jun-Ping Li; Yang Liu; Yi-Hua Yin
Journal:  Onco Targets Ther       Date:  2017-02-07       Impact factor: 4.147

8.  Evaluation of Socio-demographic Factors for Non-compliance to Treatment in Locally Advanced Cases of Cancer Cervix in a Rural Medical College Hospital in India.

Authors:  Samrat Dutta; Nandita Biswas; Goutam Muhkherjee
Journal:  Indian J Palliat Care       Date:  2013-09

9.  Disparities in cervical cancer mortality rates as determined by the longitudinal hyperbolastic mixed-effects type II model.

Authors:  Mohammad A Tabatabai; Jean-Jacques Kengwoung-Keumo; Wayne M Eby; Sejong Bae; Juliette T Guemmegne; Upender Manne; Mona Fouad; Edward E Partridge; Karan P Singh
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

10.  End-of-life expenditures by Ohio Medicaid beneficiaries dying of cancer.

Authors:  Siran M Koroukian; Heather Beaird; Elizabeth Madigan; Mireya Diaz
Journal:  Health Care Financ Rev       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.